经纤支镜瘤体内注射抗癌药治疗老年晚期中心型肺癌近期疗效

doi:10.3969/j.issn.1002-3070.2010.03.018

PRACTICAL ONCOLOGY JOURNAL ›› 2010, Vol. 24 ›› Issue (3): 268-270.doi: 10.3969/j.issn.1002-3070.2010.03.018

Previous Articles Next Articles

Received:2010-01-01 Online:2010-06-28 Published:2015-01-24

Abstract

CLC Number:

R734

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.3969/j.issn.1002-3070.2010.03.018

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2010/V24/I3/268

[1]	LU Juping, HU Jun, DENG Yongming, LIAO Shufang. Downregulation of FKBP4 inhibits the malignant progression of non-small cell lung cancer by blocking the PI3K/Akt/mTOR signaling pathway [J]. Journal of Practical Oncology, 2025, 39(3): 184-190.
[2]	GUO Xueyun, XU Yunfeng, CHU Shangqi, RUAN Fuxiang. The correlation between EGF gene polymorphism and sensitivity of concurrent chemoradiotherapy regimen containing cisplatin in esophageal cancer patients [J]. Journal of Practical Oncology, 2025, 39(3): 216-223.
[3]	LI Caizheng, ZHENG Jing, SU Qiaoli. Advance progress in immunotherapy for unresectable locally advanced non-small cell lung cancer [J]. Journal of Practical Oncology, 2025, 39(1): 67-72.
[4]	XU Xianhui, CHEN Yang, ZHU Yunfang, LI Mingsong, WEN Hongmei. Incidence and mortality of lung cancer in cancer registration areas of Yunnan province in 2020 and the trends from 2012 to 2020 [J]. Journal of Practical Oncology, 2024, 38(6): 367-371.
[5]	CHEN Xingyan, LI Xue, FU Qiang. Research progress of RNA methylation in lung cancer [J]. Journal of Practical Oncology, 2024, 38(6): 421-426.
[6]	HAO Huiting, ZHAO Huijuan, XU Qiaohui. Expression and clinical significance of hypermethylated in cancer 1 in non-small cell lung cancer [J]. Journal of Practical Oncology, 2024, 38(5): 306-312.
[7]	XU Lingyan, LI Qianni, LI Jian, YAO Xuepei, LIU Meina. Analysis for the impact of the first hospitalization days on treatment quality in patients with non-small cell lung cancer [J]. Journal of Practical Oncology, 2024, 38(4): 221-226.
[8]	YAO Xuepei, BAI Shanqi, LIU Meina. Analysis of factors influencing treatment quality of non-small cell lung cancer based on causal diagram model [J]. Journal of Practical Oncology, 2024, 38(4): 227-234.
[9]	MA Na, LIU Jie. Analysis of lung cancer incidence and mortality in Hedong district,Tianjin,from 2015 to 2020 [J]. Journal of Practical Oncology, 2024, 38(4): 241-245.
[10]	CHENG Yongming, DONG Huanhuan, XU Hui. Hsa-let-7b-5p inhibits proliferation,migration and invasion in non-small cell lung cancer [J]. Journal of Practical Oncology, 2024, 38(3): 157-167.
[11]	WANG Wenbo, BAI Haixin, ZHANG Tan, NIU Li. Propofol inhibits glycolysis and tumor progression in lung cancer through GLUT4 [J]. Journal of Practical Oncology, 2024, 38(2): 104-111.
[12]	BO Yun, HANG Wenlu, ZUO Shurun, Dong Yuan, LI Haiquan. Effects of long non-coding RNA OTUD6B-AS1 on proliferation,invasion and migration of lung adenocarcinoma A549 cells [J]. Journal of Practical Oncology, 2024, 38(1): 13-17.
[13]	ZHANG Xuan, LI Xin, ZHAO Kang. Relationship between serum inflammatory markers and prognosis of advanced non-small cell lung cancer patients treated with first-line immunosuppressants [J]. Journal of Practical Oncology, 2024, 38(1): 37-44.
[14]	CAO Yingyue, PANG Luyi, ZHANG Jian, JIN Shi. The role of cancer-associated fibroblasts in the progression of non-small cell lung cancer [J]. Journal of Practical Oncology, 2023, 37(4): 383-388.
[15]	CHEN Qi, HE Mingxv, JIA Keliang, MIAO Jianlong, HAN Liping. Research progress on the prognosis and treatment of non-small cell lung cancer with TP53-EGFR co-mutation [J]. Journal of Practical Oncology, 2023, 37(3): 262-266.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments